Biomechanical Properties of Decellularized Porcine Pulmonary Valve Conduits
|
|
- Ami Evans
- 6 years ago
- Views:
Transcription
1 Artificial Organs ( ):, Blackwell Publishing, Inc. 2007, Copyright the Authors Journal compilation 2007, International Center for Artificial Organs and Transplantation Biomechanical Properties of Decellularized Porcine Pulmonary Valve Conduits *Gernot Seebacher, Christian Grasl, Martin Stoiber, Erwin Rieder, *Marie-Theres Kasimir, Daniela Dunkler, *Paul Simon, *Günter Weigel, and Heinrich Schima *Department of Cardiothoracic Surgery, Medical University of Vienna; Institute of Biomedical Engineering and Physics, Medical University of Vienna; Department of General Surgery, Medical University of Vienna; Core Unit for Medical Statistics and Informatics, Medical University of Vienna; and Ludwig Boltzmann Cluster for Cardiovascular Research, Medical University of Vienna, Vienna, Austria Abstract: Tissue-engineered heart valves constructed from a xenogeneic or allogeneic decellularized matrix might overcome the disadvantages of current heart valve substitutes. One major necessity besides effective decellularization is to preserve the biomechanical properties of the valve. Native and decellularized porcine pulmonary heart valve conduits (PPVCs) (with [n = 10] or without [n = 10] cryopreservation) were compared to cryopreserved human pulmonary valve conduits (n = 7). Samples of the conduit were measured for wall thickness and underwent tensile tests. Elongation measurement was performed with a video extensometer. Decellularized PPVC showed a higher failure force both in longitudinal (+73%; P < 0.01) and transverse (+66%; P < 0.001) direction compared to human homografts. Failure force of the tissue after cryopreservation was still higher in the porcine group (longitudinal: +106%, P < 0.01; transverse: +58%, P < 0.001). In comparison to human homografts, both decellularized and decellularized cryopreserved porcine conduits showed a higher extensibility in longitudinal (decellularized: +61%, P < 0.001; decellularized + cryopreserved: +51%, P < 0.01) and transverse (decellularized: +126%, P < 0.001; decellularized + cryopreserved: +118%, P < 0.001) direction. Again, cryopreservation did not influence the biomechanical properties of the decellularized porcine matrix. Key Words: Tissue engineering Heart valve Biomechanical testing. The limited durability of conventionally used biological heart valve substitutes, and the consecutive high risk of thromboembolic events and bleeding after implantation of mechanical valve prostheses, are still major problems in cardiovascular surgery that remain unsolved (1,2). Due to limited durability and the lack of growth potential of current artificial heart valves especially in young patients who would benefit from a new durable biological heart valve, tissue engineering as a multidisciplinary approach doi: /j x Received September 2006; revised February Address correspondence and reprint requests to Dr. Günter Weigel, Department of Surgery, Division of Cardiothoracic Surgery, Surgical Research Laboratories, Medical University of Vienna, Vienna, Austria. guenter.weigel@meduniwien. ac.at could help to develop alternative devices. But the durable, nonimmunogenic, and nonthrombogenic heart valve prosthesis with the ability to grow is still not available (3 5). The decellularization approach of xenogeneic heart valves might be one option besides the use of biodegradable polymer as scaffolds for tissue engineering purposes. For clinical implementation, not only a thorough decellularization and eventual reseeding are needed, but also biomechanical stability has to be preserved. In former studies, we could demonstrate the decellularization of heart valve material and the successful seeding with human cells (6). The present study was carried out to describe the effects of decellularization, freezing, and thawing on the biomechanical properties of porcine heart valve tissue, and for the first time these data were compared to the stability of conventionally used homograft heart valve tissue. 1
2 2 G. SEEBACHER ET AL. C min 30 min 45 min 60 min 75 min 90 min FIG. 1. Schematic presentation of the temperature gradient used for cryopreservation of heart valve conduits. MATERIALS AND METHODS Porcine pulmonary heart valve conduits (PPVCs) (n = 10) of pigs ( kg) were obtained from a local slaughterhouse. Within 2 h after explantation, the conduits were incubated in sterile water containing an antibiotic solution with vancomycin (12 mg/l), metronidazole (12 mg/l), amikacin (12 mg/l), and ciprofloxacine (3 mg/l) for 48 h at 4 C. Six porcine pulmonary conduits were treated with a detergentbased decellularization procedure as previously described (6). Briefly, the conduits were placed into 100-mL sterile water containing 0.05% tert-octylphenyl-polyoxyethylene (Triton X-100, Bio-Rad, Hercules, CA, USA), 0.05% sodiumdeoxycholate (Merck, Darmstadt, Germany), and 0.05% octylphenyl-polyethylene glycol (IGEPAL- CA630, ICN,Aurora, OH, USA) for 48 h at 4 C. Conduits were subsequently treated with ribonuclease (100 mg/ml) (RNase, Roche Diagnostics GmbH, Mannheim, Germany) and deoxyribonuclease (150 IU/mL) (DNase, Sigma, St. Louis, MO, USA) with 50-mmol/L MgCl 2 in phosphate buffered saline (Ca ++ and Mg ++ free; PBS /, Gibco, Paisley, Scotland) for 24 h at 37 C. To remove residual detergents, the heart valve conduits were subsequently washed for 12 days in PBS / changed every second day, with an additional antibiotic sterilization carried out for at least 3 days at the end of the washing procedure. All steps were conducted under continuous shaking. For detection of tissue integrity and cell removal, histological examination was performed. Two longitudinal slices excised from each decellularized conduit were embedded in paraffin. Three sections (10 mm) of each slice were stained with hematoxylineosin (HE) and examined by two independent assistants. To exclude the presence of nucleic remnants, immunofluorescent staining with the DNAspecific dye TOPRO-3 (Molecular Probes, Leiden, The Netherlands) was performed. Human pulmonary heart valves were obtained in the course of heart transplantations. Valve conduits (n = 7) that could not be used for implantation as homograft substitutes for several reasons (e.g., valvular incompetence) were cryopreserved after antibiotic sterilization (approved by the Ethics Committee of the Medical University of Vienna). Cryopreservation Porcine valve conduits (native or decellularized) and cadaveric homografts were treated according to European tissue bank standards (7) and stored at -180 C until use. In brief, valve conduits were cryopreserved in sterile tubes containing RPMI 1640 medium and 10% (vol/vol) dimethyl sulfoxide. Cryopreservation was carried out in an automatic freezing device (Ice Cube 1610 Computer Freezer, SY-LAB, Neupurkersdorf, Austria) using the gradient depicted in Fig. 1. Mechanical testing Tests were performed with a universal tensile tester (Meßphysik Beta 10-2,5, Messphysik Labongeräte GesmbH, Fürstenfeld, Austria) and a 50-N force transducer (Hottinger Baldwin Type 70-2, Hottinger Baldwin Messtechnik GmbH, Darmstadt, Germany) according to a modified procedure presented by Korossis et al. (8). Elongation was measured with a video extensometer (Meßphysik ME46, Messphysik Laborgeräte GesmbH) between the two elongation measurement marks on the specimen (Fig. 2). This optical strain measurement ensures to measure the real elongation at the specimen and therefore avoids measuring errors caused by clamping. The specimens were punched out of the tissue with a specially designed punching tool. The specimens are dumbbell-shaped, mm overall in size, 6 7 mm in the gauge area (Fig. 2). Due to variation of wall thickness within one conduit and even within one specimen, measurement FIG. 2. Test sample with applied elongation measurement marks. Dumbbell-shaped test sample, 25 mm long and 10 mm broad; arrows show the position of the elongation measurement marks applied in the narrow part of the sample.
3 DECELLULARIZATION AND BIOMECHANICAL PROPERTIES 3 TABLE 1. Allocation of the samples that was matched in the porcine tissue groups whereas a slight hangover compared to the sample size in the homograft group must be reported Group Conduits n Longitudinal samples n Transverse samples n Porcine, native Porcine, native, cryo Porcine, decell Porcine, decell, cryo Human, cryo of the sample cross section necessary for calculation of tensile strength seems impractical. Therefore, we chose to present the mechanics of the tissue in terms of tension or force per unit width of specimen. This method ignores thickness and avoids the effect of varying tissue thickness within the specimen. Nevertheless, the thickness of all tissue specimens was measured with a vernier caliper and an averaged thickness value for each matrix group was calculated. Tissue specimens were gripped in the tensile tester by brass clamps with attached sand paper to prevent slipping. The tissue was loaded at 10 mm/min until rupture of the sample; the data from the load cell and the strain between the elongation marks were recorded online by the built-in personal computer. From the recorded load data, the tension was calculated according to the formula: T = F/I, where T is the tension in N/mm, F is the acquired force in Newtons (N), and I is the width of the specimen in millimeters (mm). Strain was calculated from the extension data according to the formula: e=dl/l 0 100, where e is the strain expressed in % of specimen elongation, Dl the extension of the specimen in mm, and l 0 the original length of the specimen in mm, at zero stress. Study groups Studies on five different groups of biological heart valve conduits were performed in order to obtain information about the natural strength of the material and to evaluate the influence of decellularization and preservation on the biomechanical stability of the matrix: Group 1: native, PPVC. Group 2: native, but cryopreserved PPVC. Group 3: decellularized PPVC. Group 4: decellularized and cryopreserved PPVC. Group 5: native, human cryopreserved pulmonary homografts. Each treatment group provided samples for biomechanical testing that were punched out of the pulmonary trunk in the size of mm (Fig. 1) in longitudinal and transverse direction and marked with ballpoint ink for elongation measurement. Details about the specimens that underwent biomechanical testing are given in Table 1. Statistics Load at failure normalized to the width of the specimen and strain at failure were analyzed and compared between the different groups of valve conduits. All values are shown as mean SD. Maximum strain and maximum tension in longitudinal and transverse directions are graphically summarized in boxplots. Wilcoxon s signed-rank test was used to assess the differences between the groups. Calculation was done by SPSS software package 14.0 (SSPS, Inc., Chicago, IL, USA). A P value less than 0.05 was considered significant. RESULTS Decellularization After the decellularization process, no microscopy cells or cell remnants could be detected within the examined porcine tissue sections, neither by light (HE staining) nor by immunofluorescence (TOPRO- 3-staining), which is in accordance with recent findings (6). A representative photomicrograph is shown in Fig. 3. Biomechanical testing No statistically significant differences of tension were observed between native and decellularized porcine specimens, thus indicating the preservation of biomechanical stability during decellularization of PPVC. Compared to human homografts, tension of decellularized PPVC was statistically significantly higher in longitudinal (P < 0.05, Fig. 4a) as well as in transverse direction (P < 0.001, Fig. 4b). Rupture of the porcine tissue occurred at much higher levels of strain. In longitudinal direction, the strain level of decellularized porcine samples was % while
4 4 G. SEEBACHER ET AL. FIG. 3. HE (left, 200 ) and TOPRO-3- staining (right, laser scanning microscopy 400 ) of tissue sections. After decellularization, no cell remnants could be detected, neither with HE staining nor with TOPRO-3-staining. human tissue showed a level of 71 30% (P < 0.001, Fig. 5a). In specimens punched out in transverse direction, the difference was even higher (P < 0.001, Fig. 5b). Porcine tissue reached a maximum strain of % while human tissue ruptured at a mean strain level of 47 18%. Cryopreservation did not alter the extensibility of the decellularized porcine tissue. Decellularized cryopreserved PPVC revealed a significantly higher tension than did human homografts in longitudinal (P < 0.01, Fig. 4a) as well as in transverse direction (P < 0.001, Fig. 4b). Results similar to that obtained in force experiment were found when measuring the extensibility in longitudinal (P < 0.01, Fig. 5a) and transverse direction (P < , Fig. 5b). The porcine conduits had a mean thickness of 2.2 mm and the human homograft of 1.4 mm (Fig. 6). Moreover, a comparison of decellularized porcine cryopreserved tissue with porcine native (with or without cryopreservation) and porcine decellularized specimens without cryopreservation, did not show any significant differences concerning tension and failure strain both in longitudinal and transverse directions. DISCUSSION As currently used cardiovascular prostheses are far from being the ideal substitute due to major postimplant complications such as thromboembolic events or early degradation and calcification, efforts have been undertaken in the evaluation and development of bioartificial heart valve substitutes. Tissue engineering, defined as the regeneration of tissue by cell transplantation with the aid of supporting structures, is thought to overcome the obstacles of artificial tissue prostheses in cardiovascular surgery. Two major principles are followed in matrix research: (i) development of biodegradable polymer constructs emulating the initial anatomical structure; and (ii) decellularization of preformed tissue, such as heart valves or blood vessels is under investigation. Decellularization generally refers to the removal of cells and cellular remnants while leaving a biological material composed essentially of extracellular matrix (ECM) components. The concept of decellularization or tissue engineering of heart valves was developed and modified by several groups (6,7,9 11). It is believed that the process of decellularization can reduce or eliminate the immune response or calcification associated with nonautologous cells and cell membranes. However, due to extraction of cells, it can be hypothesized that some components of the ECM are simultaneously removed, thus influencing the biomechanical properties of decellularized tissue. Hopkins (12) suggested to carefully define and measure the degradation occurring during decellularization and to relate them to appropriate standards derived from similar measurements of fresh human functioning heart valves. If a decellularization process weakens relevant physical properties of the putative transplant valve below a level where safety can be ensured, then additional steps will be needed to strengthen the ECM platform. This study has been designed to evaluate whether a decellularization procedure will alter the biomechanical properties of a PPVC in comparison with a conventional pulmonary homograft root. As for logistic purposes (e.g., shipping), freezing and thawing cycles might be included. Therefore, cryopreserved tissue samples were tested for their biomechanical performance. Although biomechanical testing was used in the evaluation of heart valves, most studies were focusing on aortic material and due to very heterogeneous
5 % strain Newton/millimeter DECELLULARIZATION AND BIOMECHANICAL PROPERTIES 5 a a 2, ,00 2,000 % strain 150,00 *** ** 1,500 ** * 100,00 1,000 50,00 0,500 porcine native porcine decell human homograft porcine cryo porcine cryo decell Groups porcine native porcine decell human homograft porcine cryo porcine cryo decell Groups b b 2,500 *** *** 200 Newton/millimeter 2, *** *** 1, , ,500 porcine native porcine decell human homograft porcine cryo porcine cryo decell Groups FIG. 4. (a) Maximum tension in longitudinal direction. Maximum force that the different materials could withstand until rupture (N/mm). Force was applied in longitudinal direction of the bloodstream. Porcine decellularized samples showed statistically significant higher tension than did human homografts (*P < 0.05). Porcine decellularized and cryopreserved tissue was even more resistant compared to human homografts (**P < 0.01). Wilcoxon s signed-rank test. (b) Maximum tension in transverse direction. Maximum force that the different materials could withstand until rupture (N/mm). Force was applied in transverse direction of the bloodstream. Porcine decellularized samples as well as porcine decellularized and cryopreserved tissue showed statistically significant higher tension than did human homografts (***P < 0.001). Wilcoxon s signed-rank test. porcine native porcine decell human homograft porcine cryo porcine cryo decell Groups FIG. 5. (a) Maximum strain in longitudinal direction. Maximum strain that the different materials could withstand until rupture (percentage of elongation compared to the original length of the specimen). Force was applied in longitudinal direction of the bloodstream. Porcine cryopreserved decellularized samples showed statistically significant higher strain than did human homografts (**P < 0.01). Porcine decellularized tissue was even more extensible compared to human homografts (***P < 0.001). Wilcoxon s signed-rank test. (b) Maximum strain in transverse direction. Maximum strain that the different materials could withstand until rupture (percentage of elongation compared to the original length of the specimen). Force was applied in transverse direction of the bloodstream. Porcine decellularized samples as well as porcine decellularized and cryopreserved tissue were statistically equal but showed both higher extensibility than did human homografts (***P < 0.001). Wilcoxon s signed-rank test.
6 6 G. SEEBACHER ET AL. wall thickness [mm] 3 2,5 2 1,5 1 0,5 0 homograft porcine decellularized, cryopreserved porcine decellularized porcine cryopreserved porcine native FIG. 6. Mean values of the wall thickness from each study group. mechanical tests, comparison and learning from these data are difficult. Lu et al. (13) tested tissue samples derived from porcine aortic walls and compared completely decellularized collagen and elastin scaffolds in stress strain. Collagen scaffolds exhibited lower tensile strength and lower distensibility than did fresh aorta while elastin scaffolds maintained their distensibility but had reduced tensile strength. Other studies investigated native aortic leaflets and compared them with those that were decellularized, polymer coated, and glutaraldehyde fixed (14 16). Hybrid heart valve scaffolds were fabricated from decellularized porcine aortic heart valve matrices and enhanced with bioresorbable polymers, and properties of the hybrid structures were compared with native, decellularized, and glutaraldehyde-fixed specimens. It was demonstrated that polymer impregnation stiffened the leaflets and increased tensile strength unlike polymer coating which exhibited a converse behavior with diminishing stiffness and tensile strength. Comparing human aortic and pulmonary roots as well as cusps on their biomechanical behavior has shown that pulmonary roots are more distensible and less compliant when loaded to aortic pressures. The pulmonary valve cusp and root tissue also showed greater extensibility and greater stiffness (lower compliance) when subjected to the same loads. Mechanical differences therefore were minimal between aortic and pulmonary valve tissues. It was postulated that the pulmonary root should withstand the forces imposed on it when placed in the aortic position. However, the pulmonary root will distend about 30% more than the aortic root when subjected to aortic pressures. These geometric changes may affect valve function in the long term and should be appreciated when implanting a pulmonary valve graft (16). Elkins et al. (17) compared native and decellularized wall and leaflet tissue of human pulmonary arteries. Samples were evaluated under uniaxial testing and compared with cryopreserved human pulmonary valve tissue. Samples of conduit and myocardium were also evaluated for suture retention ability. Furthermore, the valves underwent hydrodynamic testing and interestingly no alterations of biomechanical properties could be detected. A comparison of porcine native and acellular pulmonary leaflets revealed a loss of integrity with increasing decellularization time (18). Another study demonstrated that decellularization of porcine pulmonary leaflets leads to a significant loss of strength in radial and circumferential direction, but after reseeding in a bioreactor, a significant increase in stability was regained and was comparable with the mechanical properties of native ovine and porcine tissues. Biochemical and mechanical analyses revealed a continuous increase of cell mass, collagen, and elastin contents as well as an increase of strength under pulsatile culture conditions compared to significantly lower values in the static controls (19). Also calf pericardium, native or cell extracted, was tested for its biomechanical properties (20). No significant difference could be observed for fracture tension or percentage of strain at fracture. Mechanical properties of the fresh tissue seemed to be preserved in the pericardial acellular matrix. In the present study, biomechanical testing of porcine pulmonary conduits revealed that the extensibility of native but also of decellularized porcine pulmonary conduit tissue is significantly higher when compared to human homograft tissue. In contrast, the tension of the homograft tissue was much lower than that of porcine conduits. This different biomechanical characteristic can be explained by the smaller wall thickness of the homograft. Moreover, a comparison of decellularized porcine cryopreserved tissue with porcine native (with or without cryopreservation) and porcine decellularized specimens without cryopreservation, did not show any significant differences concerning tension and failure strain both in longitudinal and transverse directions. This clearly indicates that the several steps during processing of porcine pulmonary tissue (decellularization, cryopreservation, and thawing) do not alter tissue integrity that would result in impaired biomechanical stability. Cryopreservation is mandatory for planning optimal time of valve replacement and having the possibility of storage of a certain pool of valves in case of immediate and acute surgery.
7 DECELLULARIZATION AND BIOMECHANICAL PROPERTIES 7 2,5 2 Force [N/mm] 1,5 1 decellularized, transversal homograft, transversal FIG. 7. Stress strain curves of transverse specimens of a cryopreserved homograft and a cryopreserved decellularized PPVC. Decellularized porcine tissue revealed a longer elastin phase than did a homograft, while the collagen phase of the curve and the transition phase run parallel. 0, Strain [%] Regarding the stress strain curve of the porcine tissue, a longer elastin phase for porcine tissue could be observed while the collagen phase showed a parallel course (Fig. 7). It could be estimated that the elastin concentration is higher in porcine pulmonary conduits than in human homografts which might be responsible for the higher extensibility observed in our experimental setting. To the best of our knowledge, this is the first study comparing decellularized vascular material with conventionally used homograft valve tissue regarding mechanical properties. Our results demonstrate that cell-extracted porcine cardiovascular tissue should perform similarly to native tissue in an in vivo setting. However, as it has been shown that even after decellularization, an immune response toward porcine tissue will occur, the mechanical properties of the acellular tissue might be impaired due to inflammatory reactions and could explain the aneurysmatic alterations of decellularized xenogeneic vascular substitutes described after in vivo implantation. Although many issues on decellularized xenogeneic cardiovascular tissue are still to be solved, our results give new important information on the safety of tissue-engineered cardiovascular prostheses. REFERENCES 1. Cannegieter SC, Rosendaal FR, Briet E. Thromboembolic and bleeding complications in patients with mechanical heart valve prostheses. Circulation 1994;89: Teoh KH, Ivanov J, Weisel RD, Darcel IC, Rakowski H. Survival and bioprosthetic valve failure. Ten year follow up. Circulation 1998;80: Breuer CK, Mettler BA, Anthony T, Sales VL, Schoen FJ, Mayer JE. Application of tissue-engineering principles toward the development of a semilunar heart valve substitute. Tissue Eng 2004;10: Flanagan TC, Pandit A. Living artificial heart valve alternatives. A review. Eur Cell Mater 2003;6: Neuenschwander S, Hoerstrup SP. Heart valve tissue engineering. Transpl Immunol 2004;12: Rieder E, Kasimir MT, Silberhumer G, et al. Decellularization protocols of porcine heart valves differ importantly in efficiency of cell removal and susceptibility of the matrix to recellularization with human vascular cells. J Thorac Cardiovasc Surg 2004;127: Parker P, Hunt C. European Association of Tissue Banks standards for cryopreserved cardiovascular tissue banking. Cell Tissue Bank 2000;1: Korossis SA, Booth C, Wilcox HE, et al. Tissue engineering of cardiac valve prostheses II: biomechanical characterization of decellularized porcine aortic heart valves. J Heart Valve Dis 2002;11: Lee JM, Haberer SA, Boughner DR. The bovine pericardial xenograft: I. Effect of fixation in aldehydes without constraint on the tensile viscoelastic properties of bovine pericardium. J Biomed Mater Res 1998;23: Schoen FJ. Aortic valve structure-function correlations: role of elastic fibers no longer a stretch of the imagination. J Heart Valve Dis 1997;6: Rieder E, Seebacher G, Kasimir MT, et al. Tissue engineering of heart valves: decellularized porcine and human valve scaffolds differ importantly in residual potential to attract monocytic cells. Circulation 2005;111: Hopkins RA. Tissue engineering of heart valves decellularized valve scaffolds. Circulation 2005;111: Lu Q, Ganesan K, Simionescu DT, Vyavahare NR. Novel porous aortic elastin and collagen scaffolds for tissue engineering. Biomaterials 2004;25: Grabow N, Schmohl K, Khosravi A, et al. Mechanical and structural properties of a novel hybrid heart valve scaffold for tissue engineering. Artif Organs 2004;28: Spina M, Ortolani F, Messlemani AE, et al. Isolation of intact aortic valve scaffolds for heart-valve bioprostheses: extracellular matrix structure, prevention from calcification, and cell repopulation features. J Biomed Mater Res 2003;67A: Vesely I, Casarotto D, Gerosa G. Mechanics of cryopreserved aortic and pulmonary allografts. J Heart Valve Dis 2000;9: Elkins RC, Dawson PE, Goldstein S, Walsh SP, Black KS. Decellularized human valve allografts. Ann Thorac Surg 2001;71:S Schenke-Layland K, Vasilevski O, Opitz F, et al. Impact of decellularization of xenogenic tissue on extracellular matrix
8 8 G. SEEBACHER ET AL. integrity for tissue engineering of heart valves. J Struct Biol 2003;143: Schenke-Layland K, Opitz F, Gross M, et al. Complete dynamic repopulation of decellularized heart valves by application of defined physical signals an in vitro study. Cardiovasc Res 2003;60: Courtman DW, Pereira CA, Kashef V, McComb D, Lee JM, Wilson GJ. Development of a pericardial acellular matrix biomaterial: biochemical and mechanical effects of cell extraction. J Biomed Mater Res 1994;28:
Tissue Engineering of the Mitral Valve Leaflets and Abdominal Aorta
Medizinische Hochschhule Hannover Dr Morticelli L Supervisor: Dr Korossis S Niedersächsischen Zentrum für Biomedizintechnik und Implantatforschung The Tissue Engineering (TE) Concept Tissue Engineering
More informationB.-T. YU, W.-T. LI, B.-Q. SONG, Y.-L. WU. Introduction. Abstract. BACKGROUND: Valve replacement
European Review for Medical and Pharmacological Sciences Comparative study of the Triton X-100-sodium deoxycholate method and detergent-enzymatic digestion method for decellularization of porcine aortic
More informationArtificial blood vessels
Artificial blood vessels S. Swaminathan Director Centre for Nanotechnology & Advanced Biomaterials School of Chemical & Biotechnology SASTRA University Thanjavur 613 401 Tamil Nadu Joint Initiative of
More informationValvular heart disease is an important source of morbidity. Tissue Engineering of Heart Valves: In Vitro Experiences
Tissue Engineering of Heart Valves: In Vitro Experiences Ralf Sodian, MD, Simon P. Hoerstrup, MD, Jason S. Sperling, MD, Sabine H. Daebritz, MD, David P. Martin, PhD, Frederick J. Schoen, MD, PhD, Joseph
More information1) Determining the best cell sources and scaffold materials for TEHV development.
Broadly speaking, my primary research interests focus on the development and application of methodologies that can be employed in the basic understanding and optimization of tissue engineered heart valves
More informationThe Biomechanics of ProLayer Acellular Dermal Matrix: suture retention strength
The Biomechanics of ProLayer Acellular Dermal Matrix: suture retention strength Reginald Stilwell, B.S., C.T.B.S., Ryan Delaney, M.S. ProLayer, Centennial, CO Basic science volume 2 ProLayer Acellular
More informationPROJECT STATEMENT AND SPECIFICATIONS THREE POINT BENDING DEVICE FOR FLEXURE TESTING OF SOFT TISSUES
PROJECT STATEMENT AND SPECIFICATIONS THREE POINT BENDING DEVICE FOR FLEXURE TESTING OF SOFT TISSUES TEAM 4 Michael Harman Minh Xuan Nguyen Eric Sirois CLIENT CONTACT Wei Sun, Ph.D. Assistant Professor
More information1 Publishable summary
1 Publishable summary 1.1 Summary of project objectives Valve replacement with mechanical or bioprosthetic prostheses is the most common intervention for valvular disease, with almost 300.000 annual replacements
More informationBioreactors in tissue engineering
Bioreactors in tissue engineering S. Swaminathan Director Centre for Nanotechnology & Advanced Biomaterials School of Chemical & Biotechnology SASTRA University Thanjavur 613 401 Tamil Nadu Joint Initiative
More informationThoughts and Progress
aor_1007 69..91 Artificial Organs 35(1):69 91, Wiley Periodicals, Inc. 2010, Copyright the Authors Artificial Organs 2010, International Center for Artificial Organs and Transplantation and Wiley Periodicals,
More informationAnnual Results Presentation 23 rd May 2016 Ian Jefferson - CFO
Annual Results Presentation 23 rd May 2016 Ian Jefferson - CFO 1 Financial Overview Selected Highlights Income statement 000 31 Jan 2016 31 Jan 2015 Revenue 816 100 Cost of sales (154) (32) Gross Margin
More informationACCEPTED MANUSCRIPT. In situ heart valve tissue engineering: Employing the innate immune response to do the
Accepted Manuscript In situ heart valve tissue engineering: Employing the innate immune response to do the hard work F. Zafar, MD, D.L.S. Morales, MD PII: S0022-5223(18)30839-0 DOI: 10.1016/j.jtcvs.2018.03.059
More informationIn-vitro characterization of differently processed decellularised bovine pericardium
In-vitro characterization of differently processed decellularised bovine pericardium P. Suvaneeth 1*, N.N. Divakaran 1, U.P. Ramachandra 3, V. Narayanadas 1, M.J. Abraham 1, C. Divya 1 and J. Martin 4
More informationCellular repair of damaged organs. Repopulating scaffoldings in kidney and liver
Cellular repair of damaged organs Repopulating scaffoldings in kidney and liver Mireia Caralt, MD PhD Servei Cirurgia HBP i Trasplantaments March 29, 2017 Introduction Strategies to increase the number
More informationMechano-dependent Biosynthetic Response of Micro-integrated Cells in Elastomeric Scaffolds
Mechano-dependent Biosynthetic Response of Micro-integrated Cells in Elastomeric Scaffolds Lauren Anderson 1,2, John Stella 3, and Dr. Michael Sacks 3 1 Bioengineering and Bioinformatics Summer Institute,
More informationLife Valve Project (FP7)
Life Valve Project (FP7) Prof. Dr. Dr. Simon P. Hoerstrup University and University Hospital Zurich; Switzerland Cardiovascular Surgery Research / Regenerative Medicine Center 1 LifeValve - Living autologous
More informationCarpentier-Edwards. ThermaFix Advanced Tissue Process. The only tissue process to remove both major calcium binding sites 5
Carpentier-Edwards ThermaFix Advanced Tissue Process The only tissue process to remove both major calcium binding sites 5 Prepare to change the way you think about tissue treatments The ThermaFix process
More informationFig. 1 A Tensile Test. Fig. 2 Data from Test CellScale Biomaterials Testing I
Many biological materials from skin to ligaments to blood vessel walls carry tensile loads. To function properly, these natural structures and their engineered replacements must have suitable tensile strength
More informationWhite Paper: Designing Functional Fabrics for Today s Heart Valves and Beyond
White Paper: Designing Functional Fabrics for Today s Heart Valves and Beyond Ryan Heniford Business Development Director Peter Gabriele Director, Emerging Technology How fabrics can be used in heart valves,
More informationPresent and future of regenerative medicine. Liver Transplantation
Present and future of regenerative medicine Liver Transplantation Mireia Caralt, MD PhD Servei Cirurgia HBP i Trasplantaments March 19, 2015 Introduction Strategies to increase the number of organs EXPAND
More informationFINITE ELEMENT ANALYSIS OF MICROFABRICATED POLY(GLYCEROL SEBACATE) SCAFFOLDS FOR HEART VALVE TISSUE ENGINEERING
THE PENNSYLVANIA STATE UNIVERSITY SCHREYER HONORS COLLEGE DEPARTMENT OF BIOENGINEERING FINITE ELEMENT ANALYSIS OF MICROFABRICATED POLY(GLYCEROL SEBACATE) SCAFFOLDS FOR HEART VALVE TISSUE ENGINEERING SURJYANIL
More informationANALYSIS OF EXPLANTED SILICONE/SILICA COMPOSITE BREAST IMPLANTS
ANALYSIS OF EXPLANTED SILICONE/SILICA COMPOSITE BREAST IMPLANTS Harold J. Brandon 1,2, V. L. Young 2, K.L. Jerina 1, and C.J. Wolf 3 1 Department of Mechanical Engineering, Washington University Campus
More informationResearch Article Pressure Shift Freezing as Potential Alternative for Generation of Decellularized Scaffolds
International Biomaterials Volume 2013, Article ID 693793, 6 pages http://dx.doi.org/10.1155/2013/693793 Research Article Pressure Shift Freezing as Potential Alternative for Generation of Decellularized
More informationWhat is the future of ACL reconstruction?
What is the future of ACL reconstruction? Charles J. Gatt, Jr., MD Chair, Department of Orthopaedic Surgery Rutgers Robert Wood Johnson Medical School New Brunswick, NJ Clinical question Do patients with
More informationWhole Organ Bioengineering Science & Sensibility. Doris A. Taylor, PhD, FAHA, FACC Director, Regenerative Medicine Research Texas Heart Institute
Whole Organ Bioengineering Science & Sensibility Doris A. Taylor, PhD, FAHA, FACC Director, Regenerative Medicine Research Texas Heart Institute Disclosure Founder/Consultant/shareholder Miromatrix Medical
More informationTissue Engineering of Aortic Heart Valve: New Directions
International Conference on Mechanical, Industrial and Materials Engineering 2013 (ICMIME2013) 1-3 November, 2013, RUET, Rajshahi, Bangladesh Tissue Engineering of Aortic Heart Valve: New Directions Paper
More information3-Point Bending Device to Measure Transmural Strains for Multilayer Soft Tissue Composite
Project Statement 3-Point Bending Device to Measure Transmural Strains for Multilayer Soft Tissue Composite Team 6 Brian Schmidtberg Jen Olson Sarah Rivest Sponsor: Dr. Wei Sun Client Contact: Dr. Wei
More informationFreshman/Sophomore Junior Senior
Freshman/Sophomore Junior Senior Course Recommendations Mathematics (6 courses) MA 1021 MA 1024 (Calculus I) (Calculus IV) MA 1022 MA 2051 (Calculus II) (Differential Equations) MA 1023 MA 2611 (Calculus
More informationMechano-dependent biosynthetic response of microintegrated cells in elastomeric scaffolds.
Mechano-dependent biosynthetic response of microintegrated cells in elastomeric scaffolds. Lauren Anderson, Department of Bioengineering, The Pennsylvania State University Dr. Michael Sacks, Mentor, Department
More informationSubject Index. Antithrombotic drugs See Drugs, antithrombotic
STP898-EB/Sep. 1986 Subject Index A Absorbable vascular grafts, 197-217 Acellular vascular matrix, 219-235 Aneurysm, 58, 98 See also Failure, vascular grafts Animal experimental models baboon, endothelial
More informationTissue Engineered Vascular Grafts
Tissue Engineered Vascular Grafts Jeffrey H. Lawson, M.D., Ph.D. Chief Medical Officer Humacyte Incorporated Professor of Surgery and Pathology Duke University Medical Center Disclosure Information Financial
More informationBioartificial Surfaces
Bioartificial Surfaces Blood surface interaction E. Wolner, M. Vögele-Kadletz Medical University of Vienna Blood contact Vascular prosthesis Circulatory assist devices Heart lung machine: ECMO Artificial
More informationHeart Valve Tissue Engineering: Concepts, Approaches, Progress, and Challenges
Annals of Biomedical Engineering, Vol. 34, No. 12, December 2006 ( C 2006) pp. 1799 1819 DOI: 10.1007/s10439-006-9163-z Heart Valve Tissue Engineering: Concepts, Approaches, Progress, and Challenges KAREN
More informationSpecifically designed for abdominal wall repair STRUCTURAL
Specifically designed for abdominal wall repair STRUCTURAL The Better Approach To a Better Allograft Better Standards: Board of Directors comprised primarily of surgeons 3-years run by surgeons, for surgeons
More informationSimplest synthetic pathways (Ch. 7)
Simplest synthetic pathways (Ch. 7) A. Symbolism of organ synthesis. B. The central question of organ synthesis. C. What is required to synthesize an organ? D. Trans-organ rules of synthesis. A. Symbolism
More informationBASE 128 and BASE CONTENTS
BASE 128 and BASE CONTENTS INTRODUCTION RATIONALE FOR PRODUCT DEVELOPMENT & FORMULAS DECONTAMINATION EFFICACY OF BASE 128 RINSING EFFICACY OF BASE TISSUE SAFETY PRODUCT VALIDATION & COLLABORATIONS COMPLIANCE
More informationHsiao-Ying S Huang 1, Brittany N Balhouse 2 and Siyao Huang 1. Introduction. Original Article
Original Article Application of simple biomechanical and biochemical tests to heart valve leaflets: Implications for heart valve characterization and tissue engineering Proc IMechE Part H: J Engineering
More informationThe technologies described in this document are in development and are not available for clinical use
R...utilizes a model of direct collaboration with surgeons and interventionalists to develop the next generation of synthetic cardiovascular devices. From expandable vascular grafts to synthetic transcatheter
More informationThirupathi Kumara Raja. S, 1 Thiruselvi. T, 1 Asit Baran Mandal, 1 Gnanamani. A, 1* Adyar, Chennai Tamil Nadu, India
Supplementary File ph and redox sensitive albumin hydrogel : A self-derived biomaterial Thirupathi Kumara Raja. S, 1 Thiruselvi. T, 1 Asit Baran Mandal, 1 Gnanamani. A, 1* 1 CSIR-CLRI Adyar, Chennai Tamil
More informationRegenerative Strategies for Vascular and Lung Tissues. Laura E Niklason MD, PhD
Regenerative Strategies for Vascular and Lung Tissues Laura E Niklason MD, PhD Disclosure: Some of this work in this presentation is from Humacyte Inc. Niklason is a founder of Humacyte, and holds stock
More informationTissue Engineering for Blood Vessels
Regenerative Medicine Tissue Engineering for Blood Vessels JMAJ 47(6): 288 293, 2004 Narutoshi HIBINO and Toshiharu SHIN OKA Department of Cardiovascular Surgery, Heart Institute of Japan, Tokyo Women
More informationRESEARCH REPOSITORY.
RESEARCH REPOSITORY This is the author s final version of the work, as accepted for publication following peer review but without the publisher s layout or pagination. The definitive version is available
More informationThis article appeared in a journal published by Elsevier. The attached copy is furnished to the author for internal non-commercial research and
This article appeared in a journal published by Elsevier. The attached copy is furnished to the author for internal non-commercial research and education use, including for instruction at the authors institution
More information(12) United States Patent (10) Patent No.: US 7,883,864 B2
USOO7883864B2 (12) United States Patent (10) Patent No.: US 7,883,864 B2 Fujisato et al. (45) Date of Patent: Feb. 8, 2011 (54) METHOD OF TREATING BIOLOGICAL (52) U.S. Cl.... 435/40.5:345/1.1; 424/572
More informationWell Insert Holder in Deep Petri Dish - AVP015
Well Insert Holder in Deep Petri Dish - AVP015 Product Information Leaflet Technology for Routine Three Dimensional (3D) Cell Culture t: +44 (0)1740 625266 f: +44 (0)1740 625251 e: info@reinnervate.com
More informationThiolTracker Violet (Glutathione Detection Reagent)
ThiolTracker Violet (Glutathione Detection Reagent) Catalog nos. T10095, T10096 Table 1. Contents and storage information. Material Amount Concentration Storage* Stability ThiolTracker Violet 180 assays
More informationMaterial properties of cortical bone
Material constants Material properties of cortical bone Material constants Material properties of cortical bone Cortical bone can withstand greater stress in compression than in tension, and greater stress
More informationHeart Valve Tissue Engineering: Concepts, Approaches, Progress, and Challenges
Heart Valve Tissue Engineering: Concepts, Approaches, Progress, and Challenges The Harvard community has made this article openly available. Please share how this access benefits you. Your story matters
More informationHeart Valve Tissue Engineering: Concepts, Approaches, Progress, and Challenges
Heart Valve Tissue Engineering: Concepts, Approaches, Progress, and Challenges The Harvard community has made this article openly available. Please share how this access benefits you. Your story matters.
More informationConference Paper Biocompatibility Issues of Next Generation Decellularized Bioprosthetic Devices
Conference Papers in Science, Article ID 869240, 6 pages http://dx.doi.org/10.1155/2014/869240 Conference Paper Biocompatibility Issues of Next Generation Decellularized Bioprosthetic Devices Michele Spina,
More informationA Bio-Implants Brief January MATRACELL TM Decellularized Allograft Bio-implants
A Bio-Implants Brief January 2009 MATRACELL TM Decellularized Allograft Bio-implants MATRACELL TM Decellularized Allograft Bio-implants Critical Applications for Cardiovascular Surgery By Alyce Linthurst
More informationScaffolds Covalently Immobilized with VEGF and Angiopoietin-1 to Promote Angiogenesis In Engineered Cardiac Tissues
Scaffolds Covalently Immobilized with VEGF and Angiopoietin-1 to Promote Angiogenesis In Engineered Cardiac Tissues Loraine L.Y. Chiu 1 and Milica Radisic 1,2,3 1 Department of Chemical Engineering and
More informationNeovasc Tissue Products. July 2011
Neovasc Tissue Products July 2011 Neovasc Inc. Neovasc Inc. is a medical device company focused on products used to treat heart disease and related conditions Founded: 2000 Location: Employees: Facility:
More informationTHE EFFECTS OF POLYETHYLENE PARTICLE PHAGOCYTOSIS ON THE VIABILITY OF MATURE HUMAN MACROPHAGES BY PETER ASPINALL, KYRA BURNETT, JOE MAHER, CAT TJAN
THE EFFECTS OF POLYETHYLENE PARTICLE PHAGOCYTOSIS ON THE VIABILITY OF MATURE HUMAN MACROPHAGES BY PETER ASPINALL, KYRA BURNETT, JOE MAHER, CAT TJAN THE AUTHORS S. Xing Institute of Biomaterials and Biomedical
More informationTHE PENNSYLVANIA STATE UNIVERSITY SCHREYER HONORS COLLEGE DEPARTMENT OF BIOENGINEERING A FOUNDATIONAL STUDY OF HEART VALVE TISSUE ENGINEERING:
THE PENNSYLVANIA STATE UNIVERSITY SCHREYER HONORS COLLEGE DEPARTMENT OF BIOENGINEERING A FOUNDATIONAL STUDY OF HEART VALVE TISSUE ENGINEERING: Exploration of Natural and Synthetic Scaffold Approaches KATHERINE
More informationSeeding of Human Endothelial Cells on Valve Containing Aortic Mini-Roots: Development of a Seeding Device and Procedure
Seeding of Human Endothelial Cells on Valve Containing Aortic Mini-Roots: Development of a Seeding Device and Procedure Helmut Gulbins, MD, Anita Pritisanac, MD, Antje Uhlig, Angelika Goldemund, Bruno
More informationSynthesis and Characterization of Biodegradable Hemostat Gelatin Sponge for Surgery Application
R Iranian Journal of Pharmaceutical Sciences Summer 2008: 4(3): 193-200 www.ijps.ir Original Article Synthesis and Characterization of Biodegradable Hemostat Gelatin Sponge for Surgery Application Rana
More informationEquity. The Finest Equine Pericardium Matrix. 0,4 mm the thinnest
Equity The Finest Equine Pericardium Matrix 0,4 mm the thinnest Equity why Equity The evolution of living organisms has selected highl performance animal tissues. From the Eocene, 50 million years ago,
More informationSupporting Protocols
Supporting Protocols This protocol may be used prior to immunostaining cells, organoids, or patient-derived xenografts cultured in TissueSpec ECM Hydrogels. Introduction Cells and organoids may form complex
More informationBiaxial Mechanical Properties of the Native and Glutaraldehyde- Treated Aortic Valve Cusp: Part II A Structural Constitutive Model
Kristen L. Billiar 1 Department of Biomedical Engineering, University of Miami, Coral Gables, FL 33124 Michael S. Sacks 2 Department of Bioengineering, University of Pittsburgh, Pittsburgh, PA 15261 Biaxial
More informationEndovascular Device Testing A Survey of Requirements for Product Validation
MET A4 1p Endovascular Device Testing Info Sheet-02.qxp_MET A4 1p Endovascular Device Testing Info Sheet.qxp 05/04/2016 09:58 Page 1 Endovascular Device Testing A Survey of Requirements for Product Validation
More informationSurgiMend. Product Summary
SurgiMend Collagen Matrix for Soft Tissue Reconstruction Product Summary Because we are committed to limiting uncertainty, Integra offers SurgiMend in 1, 2, 3 or 4 mm thicknesses and in over sixty configurations,
More informationLecture Outline. History. Purpose? Func:on of Bioscaffolds. Extracellular Matrix (ECM) 12/08/15
Associate Professor Rod Dilley Dr Rob Marano Ear Sciences Centre School of Surgery Harry Perkins Research Building 4 th Floor Lecture Outline History Purpose Functions Properties Approaches to bioscaffold
More informationCharacterization and Evaluation of a Novel Tissue Engineered Aortic Heart Valve Construct
Clemson University TigerPrints All Dissertations Dissertations 12-2010 Characterization and Evaluation of a Novel Tissue Engineered Aortic Heart Valve Construct Mary Tedder Clemson University, mtedder@clemson.edu
More informationComplete dynamic repopulation of decellularized heart valves by application of defined physical signals an in vitro study
Cardiovascular Research 60 (2003) 497 509 www.elsevier.com/locate/cardiores Complete dynamic repopulation of decellularized heart valves by application of defined physical signals an in vitro study K.
More information2012-Tissue Distribution
2012-Tissue Distribution Form Approved OMB. 0990-0457 Exp. Date 06/30/2020 Welcome to the 2012 Tissue Distribution survey. Please refer to the following instructions as you complete this section of the
More informationBasics of 3D Cell Culture: Forming spheroids in the presence of extracellular matrix
Basics of 3D Cell Culture: Forming spheroids in the presence of extracellular matrix 3D Cell Culture Core (3D3C ) Facility Birck Nanotechnology Center, Discovery Park Drs. Sophie Lelièvre, Shirisha Chittiboyina,
More informationBiological Prostheses
SAPIENZA UNIVERSITA DI ROMA EHS Dipartimento di Chirurgia Generale Paride Stefanini U.O.C. di Chirurgia Generale D e Day Surgery (Direttore: Prof. P. Negro) PRG M Chirurgia della Parete Addominale (Prof.
More informationMechanical Characterization and Stimulation Solutions for Medical Device Applications
Mechanical Characterization and Stimulation Solutions for Medical Device Applications What good is an idea if it remains an idea? Try. Experiment. Iterate. Fail. Try again. Change the world. - Simon Sinek
More informationStudies on the Effect of Molecular Weight on the Degradation Rate of Biodegradable Polymer Membrane
, pp.390-394 http://dx.doi.org/10.14257/astl.2015. Studies on the Effect of Molecular Weight on the Degradation Rate of Biodegradable Polymer Membrane Yuying Xie 1, Jong-soon Park 2, Soon-kook Kang 1,1
More informationTissue Engineering For Regenerating Life. Cryopreserved Products. Tissue Corporation
Tissue Engineering For Regenerating Life Cryopreserved Products Tissue Corporation Tissue Corporation TRC (Tissue regeneration corporation) is a multi-facility institute specializing in the preparation
More informationTechnical Note. Tissue Section Imaging. Published August The most recent version of this Technical Note is posted at licor.com/bio/support.
Technical Note Tissue Section Imaging Published August 2017. The most recent version of this Technical Note is posted at licor.com/bio/support. Page 2 - Tissue Section Imaging Table of Contents Page I.
More informationTrabecular Metal Technology
Trabecular Metal Technology Alexandre Nehme Departement of Orthopedic Surgery. Saint Georges University Hospital. Beirut. The cellular structure of Tantallum (Trabecular Metal) resembles bone and approximates
More informationTissueMend Soft Tissue Repair Matrix For Biologically Inspired Augmentation of Tendon Healing. Technical Q&A
TissueMend Soft Tissue Repair Matrix For Biologically Inspired Augmentation of Tendon Healing Technical Q&A TissueMend Soft Tissue Repair Matrix For Biologically Inspired Augmentation of Tendon Healing
More informationDermaMatrix Acellular Dermis. Comparative testing.
DermaMatrix Acellular Dermis. Comparative testing. Natural, like native tissue Minimally processed Strong and flexible DermaMatrix Acellular Dermis. Human dermal collagen matrix. Unique process DermaMatrix
More informationMechanical Characterization and Stimulation Solutions for Biomaterials
Mechanical Characterization and Stimulation Solutions for Biomaterials BioDynamic Instruments Biomaterials and Tissue Characterization Application Examples Bone Bending Creep Test Clinical Need: Understand
More informationSkin Grafting. Biomaterials. Denis Suljendic Christian van der Pol
Skin Grafting Biomaterials Denis Suljendic Christian van der Pol Overview Structure and function of skin History Reasons for a skin graft Traditional methods Modern solutions Future advancements 2 Structure
More informationAXIAL PRESTRETCH IN AORTA AND EFFECT ON CIRCUMFERENTIAL DISTENSIBILITY
AXIAL PRESTRETCH IN AORTA AND EFFECT ON CIRCUMFERENTIAL DISTENSIBILITY by LUKÁŠ HORNÝ Dept. of Mechanics, Biomechanics and Mechatronics Faculty of Mechanical Engineering CZECH TECHNICAL UNIVERSITY IN PRAGUE
More informationCHARACTERIZATION AND APPLICATION OF COLLAGEN-POLYMER BASED COMPOSITE AS WOUND HEALING MATERIAL
th ICAMS 2012 4 International Conference on Advanced Materials and Systems CHARACTERIZATION AND APPLICATION OF COLLAGEN-POLYMER BASED COMPOSITE AS WOUND HEALING MATERIAL DENİZ GÜRLER, EYLEM KILIÇ Uşak
More informationHeart valve replacement represents a common surgical
Autologous Human Tissue-Engineered Heart Valves Prospects for Systemic Application Anita Mol, PhD; Marcel C.M. Rutten, PhD; Niels J.B. Driessen, MSc; Carlijn V.C. Bouten, PhD; Gregor Zünd, MD; Frank P.T.
More informationForm Follows Function: Advances in Trilayered Structure Replication for Aortic Heart Valve Tissue Engineering
Journal of Healthcare Engineering Vol. 3 No. 2 2012 Page 179 202 179 Form Follows Function: Advances in Trilayered Structure Replication for Aortic Heart Valve Tissue Engineering Dan T. Simionescu 2, Joseph
More informationThis document is a preview generated by EVS
INTERNATIONAL STANDARD ISO 25539-1 Second edition 2017-02 Cardiovascular implants Endovascular devices Part 1: Endovascular prostheses Implants cardiovasculaires Dispositifs endovasculaires Partie 1: Prothèses
More informationReendothelialization of Human Heart Valve Neoscaffolds Using Umbilical Cord-Derived Endothelial Cells
Circulation Journal Official Journal of the Japanese Circulation Society http://www.j-circ.or.jp Advance Publication by-j-stage Reendothelialization of Human Heart Valve Neoscaffolds Using Umbilical Cord-Derived
More informationWhich hydrogel preparation for immunostaining protocol should I use?
Protocol: Preparation of TissueSpec hydrogels for immunostaining This protocol may be used prior to immunostaining cells, organoids, or patient-derived xenografts cultured in TissueSpec matrix hydrogels.
More informationSterilization Techniques Influence Physical Properties and Cell-Biomaterial Interactions in Plasticized Polylactide Foam Scaffolds
Sterilization Techniques Influence Physical Properties and Cell-Biomaterial Interactions in Plasticized Polylactide Foam Scaffolds Matthieu Cuenoud, PhD 1, Salim Elias Darwiche, PhD 1, John Christopher
More informationFunctionally stratified design and manufacture of hip and knee joints
Functionally stratified design and manufacture of hip and knee joints is to develop and deliver new simulation methods for the design and manufacture of hip and knee prostheses, to be evaluated through
More informationChallenges of biological valve development
review Challenges of biological valve development The development of mechanical and bioprosthetic valvular prostheses have enhanced the survival and quality of life for countless patients. Despite the
More informationCarmen Campbell, Ann Bazar, Ping-Cheng Wu, Kathy McKenna, Melinda Henrie, Keti Troi and Kenton Gregory*
Trends Biomater. Artif. Organs, A Simple Vol 19(1), Apparatus 1-6 (2005) and Process to Produce Novel Elastin Biomaterials http://www.sbaoi.org 1 A Simple Apparatus and Process to Produce Novel Elastin
More informationTissue Engineering of Autologous Human Heart Valves Using Cryopreserved Vascular Umbilical Cord Cells
Tissue Engineering of Autologous Human Heart Valves Using Cryopreserved Vascular Umbilical Cord Cells Ralf Sodian, MD, Cora Lueders, PhD, Liv Kraemer, MD, Wolfgang Kuebler, MD, Mehdi Shakibaei, MD, Bruno
More informationHYBRID FRP ROD FOR REINFORCEMENT AND SMART-MONITORING IN CONCRETE STRUCTURE
Proceedings of the International Symposium on Bond Behaviour of FRP in Structures (BBFS 5) Chen and Teng (eds) 5 International Institute for FRP in Construction HYBRID FRP ROD FOR REINFORCEMENT AND SMART-MONITORING
More informationCELLULAR AND FIBRE-REINFORCED COMPOSITES FOR BONE ENGINEERING
16 TH INTERNATIONAL CONFERENCE ON COMPOSITE MATERIALS CELLULAR AND FIBRE-REINFORCED COMPOSITES FOR BONE ENGINEERING Manuel Bühler, Pierre-Etienne Bourban, Jan-Anders E. Månson Laboratoire de Technologie
More informationPhenotyping of transgenic pigs to determine the suitability of xenografts in the treatment of aortic diseases
Phenotyping of transgenic pigs to determine the suitability of xenografts in the treatment of aortic diseases Strauss E (1,2), Wroblewska J, Wawrzynska L, Tomczak J, Pukacki F, Kruszyna L, Zdun M, Frackowiak
More informationBioengineered self-seeding heart valves
EVOLVING TECHNOLOGY/BASIC SCIENCE Bioengineered self-seeding heart valves James E. Jordan, PhD, a J. Koudy Williams, DVM, b Sang-Jin Lee, PhD, b Devanathan Raghavan, PhD, b Anthony Atala, MD, b and James
More informationThe Construction of Cell-Density Controlled Three- Dimensional Tissues by Coating Micrometer-Sized Collagen. Fiber Matrices on Single Cell Surfaces
Electronic Supplementary Material (ESI) for RSC Advances. This journal is The Royal Society of Chemistry 2014 Page S1 Electronic Supplementary Information (ESI) for RSC Advances The Construction of Cell-Density
More informationSTRING THEORY: AN EXAMINATION OF THE PROPERTIES OF HIGH STRENGTH SUTURE MATERIALS
STRING THEORY: AN EXAMINATION OF THE PROPERTIES OF HIGH STRENGTH SUTURE MATERIALS A. Jhamb, J. Goldberg, W. Harper, A. Butler, P.J. Smitham, W.R. Walsh Surgical & Orthopaedic Research Laboratories University
More informationBEH.462/3.962J Molecular Principles of Biomaterials Spring 2003
Lecture 6: Biodegradable Polymers for Tissue Engineering Last time: Today: enzymatic degradation of solid polymers Engineering biological recognition of polymers Designing polymers for tissue engineering
More informationCHALLENGES OF 3D BIOPRINTING IN CLINICAL PRACTICE
CENTRE DE THÉRAPIE TISSULAIRE & CELLULAIRE CHALLENGES OF 3D BIOPRINTING IN CLINICAL PRACTICE Pr. D. Dufrane MD, PhD 3D-BIOPRINTING: MYTH OR REALITY? 2 REGENERATIVE MEDICINE FOR ORGAN AND TISSUE A LARGE
More informationReimagine A New Instron Way
Reimagine A New Instron Way Tissue Engineering and Regenerative Medicine 2014 Year in Review TABLE OF CONTENTS Welcome Since 1946, Instron has been dedicated to providing you with comprehensive solutions
More informationGelatin-Coated Resorbable Polymer Mesh as a Novel Scaffold for Aortic Heart Valve Tissue Engineering
Gelatin-Coated Resorbable Polymer Mesh as a Novel Scaffold for Aortic Heart Valve Tissue Engineering Laila Roudsari, BS, Chris Albers, BS, Tara Doucet, BS, Shelley Floyd, BS, Cane Hoffman, BS, Kenneth
More informationPreparation of thin slices for light microscopy
Preparation of thin slices for light microscopy Optical light microscopy course 23.10.2012 Kirsi Rilla Shortly: Histological sample preparation for microscopy 1. Fixation: To fix the tissue components
More information